84-5233-67 KEAP1 100ul 524695

※お見積書はカートで印刷できます

冷凍

特徴

  • The nuclear factor like 2 (NRF2) transcriptional activator binds antioxidant response elements (ARE) of target gene promoter regions to regulate expression of oxidative stress response genes.
  • Under basal conditions, the NRF2 inhibitor INrf2 (also called KEAP1) binds and retains NRF2 in the cytoplasm where it can be targeted for ubiquitin-mediated degradation (1).
  • Small amounts of constitutive nuclear NRF2 maintains cellular homeostasis through regulation of basal expression of antioxidant response genes.
  • Following oxidative or electrophilic stress, KEAP1 releases NRF2, thereby allowing the activator to translocate to the nucleus and bind to ARE-containing genes (2).
  • The coordinated action of NRF2 and other transcription factors mediates the response to oxidative stress (3).
  • Altered expression of NRF2 is associated with chronic obstructive pulmonary disease (COPD) (4).
  • NRF2 activity in lung cancer cell lines directly correlates with cell proliferation rates, and inhibition of NRF2 expression by siRNA enhances anti-cancer drug-induced apoptosis (5).
  • The NRF2 repressor KEAP1 contains an N-terminal BTB/POZ domain and a C-terminal KELCH domain (6,7).
  • The KELCH domain is required for interacting with NRF2 and the BTB/POZ domain functions in binding Cul3 E3 ubiquitin ligase (8-10).
  • Under normal conditions, the complex leads to the cytoplasmic sequestration and ubiquitin-mediated proteasomal degradation of NRF2.
  • Electrophilic modification of KEAP1 leads to disassociation of the NRF2/KEAP1 complex.
  • KEAP1 also targets the down regulation of NF-κB activity by targeting IKKBeta degradation (11).
  • Applications:Suitable for use in Western Blot, Immunohistochemistry and ELISA.
  • Other applications not tested.
  • Recommended Dilution:Western Blot: 1:500-1:2000, incubate membrane with diluted primary antibody in TBS, 5% milk, 0.1% Tween 20 at 4°C with gentle shaking, overnight
  • Immunohistochemistry: 1:50-1:200ELISA (peptide): 1:20,000-1:40,000Optimal dilutions to be determined by the researcher.
  • Storage and Stability:May be stored at 4°C for short-term only.
  • Aliquot to avoid repeated freezing and thawing.
  • Store at -20°C.
  • Aliquots are stable for 12 months after receipt.
  • For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

仕様

  • Size:100ul
  • Host:rabbit
  • Source Antibody:human
  • Grade:Affinity Purified
  • Purity:Purified by immunoaffinity chromatography from serum.
  • Form:Supplied as a liquid in PBS, pH 7.4, 0.02% sodium azide, 50% glycerol.
  • Specificity:Recognizes endogenous levels of total human KEAP1. Species Crossreactivity: mouse and rat
  • Isotype:IgG
  • Calc Applications Abbrev:E IHC WB
  • Calc Crossreactivity:Hu Mo Rt
  • Immunogen:Synthetic peptide corresponding to human KEAP1.
  • Swiss Prot Number:Q14145
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
84-5233-67
型番
524695
入り数
1個
標準価格
206,000円(税抜)
WEB価格
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る